A citation-based method for searching scientific literature

Jie Xu, Jing-Lan Liu, L Jeffrey Medeiros, Wenting Huang, Joseph D Khoury, Timothy J McDonnell, Guilin Tang, Ellen Schlette, C Cameron Yin, Carlos E Bueso-Ramos, Pei Lin, Shaoying Li. Eur J Haematol 2020
Times Cited: 10







List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
Heike Horn, Marita Ziepert, Claudia Becher, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Michael Hummel, Harald Stein, Martin-Leo Hansmann,[...]. Blood 2013
386
50

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
50

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
50


Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Paul N Meyer, Kai Fu, Timothy C Greiner, Lynette M Smith, Jan Delabie, Randy D Gascoyne, German Ott, Andreas Rosenwald, Rita M Braziel, Elias Campo,[...]. J Clin Oncol 2011
343
40

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
661
40

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Annette M Staiger, Marita Ziepert, Heike Horn, David W Scott, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Monika Szczepanowski, Michael Hummel,[...]. J Clin Oncol 2017
139
40

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Tina Marie Green, Ken H Young, Carlo Visco, Zijun Y Xu-Monette, Attilio Orazi, Ronald S Go, Ole Nielsen, Ole V Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen,[...]. J Clin Oncol 2012
482
30

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
David W Scott, Rebecca L King, Annette M Staiger, Susana Ben-Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W Slack, Daisuke Ennishi,[...]. Blood 2018
109
30

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
Andreas Rosenwald, Susanne Bens, Ranjana Advani, Sharon Barrans, Christiane Copie-Bergman, Mad-Helenie Elsensohn, Yaso Natkunam, Maria Calaminici, Birgitta Sander, Maryse Baia,[...]. J Clin Oncol 2019
94
30


Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
Chulin Sha, Sharon Barrans, Francesco Cucco, Michael A Bentley, Matthew A Care, Thomas Cummin, Hannah Kennedy, Joe S Thompson, Rahman Uddin, Lisa Worrillow,[...]. J Clin Oncol 2019
106
20

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Daisuke Ennishi, Aixiang Jiang, Merrill Boyle, Brett Collinge, Bruno M Grande, Susana Ben-Neriah, Christopher Rushton, Jeffrey Tang, Nicole Thomas, Graham W Slack,[...]. J Clin Oncol 2019
153
20

Double-hit B-cell lymphomas.
Sietse M Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W van Imhoff, Hanneke C Kluin-Nelemans, Evert-Jan Boerma, Philip M Kluin. Blood 2011
472
20


Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
20

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
Nathalie A Johnson, Kerry J Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J S Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa,[...]. Blood 2009
429
20

The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
Hee Sang Hwang, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Yoon Se Lee, Young Hyeh Ko, Seok Jin Kim, Won Seog Kim, Cheolwon Suh, Jooryung Huh. Ann Hematol 2018
13
20

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Anamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, Lynette M Smith, Graham W Slack, King L Tan, Laurie H Sehn, Kai Fu, Patricia Aoun, Timothy C Greiner,[...]. Br J Haematol 2014
131
20


Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
David W Scott, Anja Mottok, Daisuke Ennishi, George W Wright, Pedro Farinha, Susana Ben-Neriah, Robert Kridel, Garrett S Barry, Christoffer Hother, Pau Abrisqueta,[...]. J Clin Oncol 2015
239
20

Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.
Clémentine Sarkozy, Alexandra Traverse-Glehen, Bertrand Coiffier. Lancet Oncol 2015
105
20

Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
Karen M Chisholm, Charles D Bangs, Carlos E Bacchi, Hernan Molina-Kirsch, Athena Cherry, Yasodha Natkunam. Am J Surg Pathol 2015
59
20

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Kerry J Savage, Nancy Lee Harris, Julie M Vose, Fred Ullrich, Elaine S Jaffe, Joseph M Connors, Lisa Rimsza, Stefano A Pileri, Mukesh Chhanabhai, Randy D Gascoyne,[...]. Blood 2008
576
20

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.
Christiane Copie-Bergman, Peggy Cuillière-Dartigues, Maryse Baia, Josette Briere, Richard Delarue, Danielle Canioni, Gilles Salles, Marie Parrens, Karim Belhadj, Bettina Fabiani,[...]. Blood 2015
155
20

Advances in pathological understanding of high-grade B cell lymphomas.
Shaoying Li, Pei Lin, L Jeffrey Medeiros. Expert Rev Hematol 2018
11
20

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
David Sibon, Marion Fournier, Josette Brière, Laurence Lamant, Corinne Haioun, Bertrand Coiffier, Serge Bologna, Pierre Morel, Jean Gabarre, Olivier Hermine,[...]. J Clin Oncol 2012
120
20

C-MYC and Its Main Ubiquitin Ligase, FBXW7, Influence Cell Proliferation and Prognosis in Adult T-cell Leukemia/Lymphoma.
Yasuhito Mihashi, Mikio Mizoguchi, Yasushi Takamatsu, Kenji Ishitsuka, Hiromi Iwasaki, Monji Koga, Kazunori Urabe, Seiya Momosaki, Toshifumi Sakata, Fumiaki Kiyomi,[...]. Am J Surg Pathol 2017
15
20

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach.
Christoph Thorns, Boris Bastian, Daniel Pinkel, Ritu Roydasgupta, Jane Fridlyand, Hartmut Merz, Manuela Krokowski, Heinz-Wolfram Bernd, Alfred Christian Feller. Genes Chromosomes Cancer 2007
50
20

Novel and highly recurrent chromosomal alterations in Sézary syndrome.
Maarten H Vermeer, Remco van Doorn, Remco Dijkman, Xin Mao, Sean Whittaker, Pieter C van Voorst Vader, Marie-Jeanne P Gerritsen, Marie-Louise Geerts, Sylke Gellrich, Ola Söderberg,[...]. Cancer Res 2008
141
20

MYC on the path to cancer.
Chi V Dang. Cell 2012
20


MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Alexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, Fina Climent, Eva González-Barca, Santiago Mercadal, Iñigo Espinosa, Silvana Novelli, Javier Briones, José L Mate,[...]. Haematologica 2013
168
20

Reflecting on 25 years with MYC.
Natalie Meyer, Linda Z Penn. Nat Rev Cancer 2008
20


Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
Osnat Bairey, Adi Shacham-Abulafia, Ofer Shpilberg, Ronit Gurion. Hematol Oncol 2016
60
20


The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Jorge J Castillo, Brady E Beltran, Moo-Kon Song, Ivana Ilic, Sirpa Leppa, Heidi Nurmi, Ritsuko Seki, Silvia Uccella, Jun-Min Li, Diana O Treaba,[...]. Leuk Res 2012
38
20

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
928
20

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Asami Izu, Masahiko Sugitani, Daisuke Kurita, Masashi Sakagami, Shimon Ohtake, Yoshihito Uchino, Atsuko Hojo,[...]. Leuk Lymphoma 2016
14
20

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma.
Jin Roh, Jiwon Jung, Yourim Lee, So-Woon Kim, Hyo-Kyung Pak, A-Neum Lee, Junho Lee, Jaehyeong Cho, Hyungwoo Cho, Dok Hyun Yoon,[...]. Front Oncol 2020
5
40

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Maysaa Abdulla, Peter Hollander, Tatjana Pandzic, Larry Mansouri, Susanne Bram Ednersson, Per-Ola Andersson, Magnus Hultdin, Maja Fors, Martin Erlanson, Sofie Degerman,[...]. Am J Hematol 2020
18
20

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Georg Lenz, George W Wright, N C Tolga Emre, Holger Kohlhammer, Sandeep S Dave, R Eric Davis, Shannon Carty, Lloyd T Lam, A L Shaffer, Wenming Xiao,[...]. Proc Natl Acad Sci U S A 2008
697
20

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Andrew Davies, Thomas E Cummin, Sharon Barrans, Tom Maishman, Christoph Mamot, Urban Novak, Josh Caddy, Louise Stanton, Shamim Kazmi-Stokes, Andrew McMillan,[...]. Lancet Oncol 2019
112
20

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
20

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, Michele Spina, Randy D Gascoyne, Lei Zhang, Jocelyne Flament, Jacqueline Repici, Umberto Vitolo. Future Oncol 2016
66
20

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
754
20

A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients.
Marita Ziepert, Stefano Lazzi, Raffaella Santi, Federica Vergoni, Massimo Granai, Virginia Mancini, Annette Staiger, Heike Horn, Markus Löffler, Viola Pöschel,[...]. Haematologica 2020
8
25

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Anas Younes, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh,[...]. J Clin Oncol 2019
226
20

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Kerry J Savage, Graham W Slack, Anja Mottok, Laurie H Sehn, Diego Villa, Roopesh Kansara, Robert Kridel, Christian Steidl, Daisuke Ennishi, King L Tan,[...]. Blood 2016
113
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.